icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
MAGELLAN-2: SAFETY AND EFFICACY OF GLECAPREVIR/PIBRENTASVIR IN LIVER OR RENAL TRANSPLANT ADULTS WITH CHRONIC HEPATITIS C GENOTYPE 1-6 INFECTION
 
 
  Reported by Jules Levin
EASL 2017 April 19-22 Amsterdam Netherlands
 
Nancy Reau1, Paul Y. Kwo2, Susan Rhee3, Robert S. Brown, Jr.4, Kosh Agarwal5, Peter Angus6, Ed Gane7, Jia-Horng Kao8, Parvez S. Mantry9, K. Rajender Reddy10, Tram T. Tran11, Yiran B. Hu3, Abhishek Gulati3, Preethi Krishnan3, Emily O. Dumas3, Nancy S. Shulman3, Roger Trinh3, Xavier Forns12
 
1Rush University Medical Center, Chicago, IL, USA; 2Stanford University School of Medicine, Palo Alto, CA, USA; 3AbbVie Inc., North Chicago, IL, USA; 4Weill Cornell Medical College, Center for Liver Disease and Transplantation, New York, NY, USA; 5Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK; 6University of Melbourne, Melbourne Australia; 7University of Auckland, Auckland, New Zealand; 8National Taiwan University Hospital, Taipei, Taiwan; 9The Liver Institute at Methodist Dallas, Dallas, TX, USA; 10University of Pennsylvania, Philadelphia, PA, USA; 11Cedars Sinai Medical Center, Los Angeles, CA, USA; 12Liver Unit, Hospital Clinic, CIBEREHD, IDIBAPS, Barcelona, Spain

CROI1

CROI2

CROI3

CROI4

CROI5

CROI6

CROI7

CROI8

CROI9

CROI10

CROI11

CROI12

CROI13